---
created: 2025-04-13
updated: 2025-04-13T10:52
id: mHf{|Y_}i<
specialty: pharmaco
specialty_id: 248
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::!flag-these-cards::temporary
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::01-hemostasis::07-anticoagulants
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::01-direct-thrombin-inhibitors
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::02-low-molecular-weight-heparin
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::02-unfractionated-heparin
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::05-direct-factor-xa-inhibitors
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::13-hematology-oncology::11-hemostasis
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::17-hem/onc-pharm::directthrombininhibitors-directfactorxainhibitors
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::17-hem/onc-pharm::heparin-lmwh-fondaparinux
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::10-heme::direct-thrombin-inhibitors-(argatroban,-dabigatran,-bivalirudin)
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::10-heme::heparin
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::03-blood-&-inflammation::01-anticoagulants-&-thrombolytics::01-heparin,-lmwh,-fondaparinux,-direct-thrombin-inhibitors,-xa-inhibitors
  - source/ak-step1-v11::^other::^highyield::4-loweryield"
type: flashcard
---

# Question
What adverse effect is common to all anticoagulants (heparin, direct thrombin inhibitors, direct Xa inhibitors, etc.)    **Bleeding**

---

# Answer
